MATAR; Majed

Patent Applications and Registrations

Patent applications and USPTO patent grants for MATAR; Majed.The latest application filed is for "nucleic acid-lipopolymer compositions".

Company Profile

0.15.19

MATAR; Majed - Madison AL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nucleic Acid-lipopolymer Compositions App 20180303957 - MATAR; Majed ; et al.	2018-10-25
Nucleic acid-lipopolymer compositions Grant 9,827,331 - Matar , et al. November 28, 2	2017-11-28
Immuno gene therapy for treatment of cancer and hyperproliferative diseases Grant 9,468,687 - Fewell , et al. October 18, 2	2016-10-18
Nucleic Acid-lipopolymer Compositions App 20160243256 - MATAR; Majed ; et al.	2016-08-25
Polyamine derivatives Grant 9,254,334 - Slobodkin , et al. February 9, 2	2016-02-09
Nucleic acid-lipopolymer compositions Grant 9,144,546 - Matar , et al. September 29, 2	2015-09-29
Polyamine Derivatives App 20150099000 - SLOBODKIN; Gregory ; et al.	2015-04-09
Polyamine derivatives Grant 8,932,638 - Slobodkin , et al. January 13, 2	2015-01-13
Polyamine derivatives Grant 8,900,621 - Slobodkin , et al. December 2, 2	2014-12-02
Combination of Immuno Gene Therapy and Chemotherapy for Treatment of Cancer and Hyperproliferative Diseases App 20140186375 - Fewell; Jason G. ; et al.	2014-07-03
Polyamine Derivatives App 20140050775 - Slobodkin; Gregory ; et al.	2014-02-20
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases Grant 8,623,837 - Fewell , et al. January 7, 2	2014-01-07
Polyamine Derivatives App 20130251809 - Slobodkin; Gregory ; et al.	2013-09-26
Polyamine derivatives Grant 8,460,696 - Slobodkin , et al. June 11, 2	2013-06-11
Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof Grant 8,445,017 - Slobodkin , et al. May 21, 2	2013-05-21
Nucleic Acid-Lipopolymer Compositions App 20130065942 - Matar; Majed ; et al.	2013-03-14
Biodegradable Cross-Linked Cationic Multi-block Copolymers for Gene Delivery and Methods of Making Thereof App 20120009145 - Slobodkin; Gregory ; et al.	2012-01-12
Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof Grant 8,057,821 - Slobodkin , et al. November 15, 2	2011-11-15
Combination of Immuno Gene Therapy and Chemotherapy for Treatment of Cancer and Hyperproliferative Diseases App 20110218231 - Fewell; Jason G. ; et al.	2011-09-08
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases Grant 7,964,571 - Fewell , et al. June 21, 2	2011-06-21
Polyamine Derivatives App 20100260817 - Slobodkin; Gregory ; et al.	2010-10-14
Modified Poloxamers for Gene Expression and Associated Methods App 20100004313 - Slobodkin; Gregory ; et al.	2010-01-07
Biodegradable Cross-Linked Branched Poly(Alkylene Imines) App 20100004315 - Slobodkin; Gregory ; et al.	2010-01-07
Nucleic Acid-Lipopolymer Compositions App 20090042829 - Matar; Majed ; et al.	2009-02-12
Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer App 20090042825 - Matar; Majed ; et al.	2009-02-12
Combination of immuno gene therapy & chemotherapy for treatment of cancer & hyperproliferative diseases App 20060127482 - Fewell; Jason G. ; et al.	2006-06-15
Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof App 20060093674 - Slobodkin; Gregory ; et al.	2006-05-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.